301 related articles for article (PubMed ID: 23430269)
1. Effects of statin treatment in patients with coronary artery disease and chronic kidney disease.
Kaneko H; Yajima J; Oikawa Y; Tanaka S; Fukamachi D; Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
Heart Vessels; 2014 Jan; 29(1):21-8. PubMed ID: 23430269
[TBL] [Abstract][Full Text] [Related]
2. Impact of aging on the clinical outcomes of Japanese patients with coronary artery disease after percutaneous coronary intervention.
Kaneko H; Yajima J; Oikawa Y; Tanaka S; Fukamachi D; Suzuki S; Sagara K; Otsuka T; Matsuno S; Funada R; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
Heart Vessels; 2014 Mar; 29(2):156-64. PubMed ID: 23552901
[TBL] [Abstract][Full Text] [Related]
3. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
4. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
[TBL] [Abstract][Full Text] [Related]
5. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry).
Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF
Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762
[TBL] [Abstract][Full Text] [Related]
6. Impact of gender difference on long-term outcomes of percutaneous coronary intervention for coronary artery disease in patients under statin treatment.
Wada H; Ogita M; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Dohi T; Kasai T; Tamura H; Okazaki S; Isoda K; Suwa S; Daida H
Heart Vessels; 2017 Jan; 32(1):16-21. PubMed ID: 27107767
[TBL] [Abstract][Full Text] [Related]
7. Additive prognostic value of coronary artery calcium score and renal function in patients with acute chest pain without known coronary artery disease: up to 5-year follow-up.
Chaikriangkrai K; Nabi F; Mahmarian JJ; Chang SM
Int J Cardiovasc Imaging; 2015 Dec; 31(8):1619-26. PubMed ID: 26243534
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and the risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents.
Miao Y; Yu-Jie Z; Zhi-Jian W; Dong-Mei S; Yu-Yang L; Ying-Xin Z; Fei G; Shi-Wei Y; De-An J
Catheter Cardiovasc Interv; 2012 Sep; 80(3):361-7. PubMed ID: 22419375
[TBL] [Abstract][Full Text] [Related]
9. Initial culprit-only versus initial multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: results from the Ibaraki Cardiovascular Assessment Study registry.
Abe D; Sato A; Hoshi T; Takeyasu N; Misaki M; Hayashi M; Aonuma K
Heart Vessels; 2014 Mar; 29(2):171-7. PubMed ID: 23529625
[TBL] [Abstract][Full Text] [Related]
10. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
[TBL] [Abstract][Full Text] [Related]
11. Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Hibi K; Terashima M; Michishita I;
Nephrology (Carlton); 2012 Sep; 17(7):628-35. PubMed ID: 22708952
[TBL] [Abstract][Full Text] [Related]
12. Long-term incidence and prognostic factors of the progression of new coronary lesions in Japanese coronary artery disease patients after percutaneous coronary intervention.
Kaneko H; Yajima J; Oikawa Y; Tanaka S; Fukamachi D; Suzuki S; Sagara K; Otsuka T; Matsuno S; Kano H; Uejima T; Koike A; Nagashima K; Kirigaya H; Sawada H; Aizawa T; Yamashita T
Heart Vessels; 2014 Jul; 29(4):437-42. PubMed ID: 23807613
[TBL] [Abstract][Full Text] [Related]
13. Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease.
Kinoshita T; Asai T; Suzuki T
J Thorac Cardiovasc Surg; 2015 Aug; 150(2):315-21.e3. PubMed ID: 26142149
[TBL] [Abstract][Full Text] [Related]
14. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
[TBL] [Abstract][Full Text] [Related]
15. Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.
Tazaki J; Morimoto T; Sakata R; Okabayashi H; Yamazaki F; Nishiwaki N; Mitsudo K; Kimura T;
J Vasc Surg; 2014 Sep; 60(3):604-12.e2. PubMed ID: 24797553
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Coronary Artery Bypass Grafting and Drug-Eluting Stents in Patients with Left Main Coronary Artery Disease and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Barbarawi M; Zayed Y; Hamid K; Kheiri B; Barbarawi O; Sundus S; Rashdan L; Alabdouh A; Chahine A; Bachuwa G; Alkotob ML
Cardiovasc Revasc Med; 2019 Dec; 20(12):1184-1189. PubMed ID: 30842042
[TBL] [Abstract][Full Text] [Related]
17. Collective impact of conventional cardiovascular risk factors and coronary calcium score on clinical outcomes with or without statin therapy: The St Francis Heart Study.
Waheed S; Pollack S; Roth M; Reichek N; Guerci A; Cao JJ
Atherosclerosis; 2016 Dec; 255():193-199. PubMed ID: 27693004
[TBL] [Abstract][Full Text] [Related]
18. The burden of major adverse cardiac events in patients with coronary artery disease.
Tsai IT; Wang CP; Lu YC; Hung WC; Wu CC; Lu LF; Chung FM; Hsu CC; Lee YJ; Yu TH
BMC Cardiovasc Disord; 2017 Jan; 17(1):1. PubMed ID: 28052754
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Coronary Artery Disease and Statins on Survival After Liver Transplantation.
Patel SS; Rodriguez VA; Siddiqui MB; Faridnia M; Lin FP; Chandrakumaran A; Laurenzano J; Clinton J; Kowlgi GN; Kirkman D; Sima AP; Liptrap E; Bhati C; Siddiqui MS
Liver Transpl; 2019 Oct; 25(10):1514-1523. PubMed ID: 31344758
[TBL] [Abstract][Full Text] [Related]
20. Impact of chronic kidney disease on patients with unprotected left main coronary artery disease treated with coronary artery bypass grafting or drug-eluting stents.
Pan Y; Qiu Q; Chen F; Li X; Yu X; Luo Y; Li Q; He J; Gao Y; Zhang X; Ren X
Coron Artery Dis; 2016 Nov; 27(7):535-42. PubMed ID: 27269882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
